BOSTON SCIENTIFIC CORP (BSX) Financials
Annual revenue, profitability and per-share results for BOSTON SCIENTIFIC CORP, as reported in SEC filings.
Revenue · FY2025
$20.07B
▲ 19.9%YoY
Net income · FY2025
$2.89B
▲ 56.7%YoY
Gross margin · FY2025
69.0%
Diluted EPS · FY2025
$1.94
▲ 55.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $20.07B | $2.89B | $13.85B | $1.94 | $3.66B | 18.0% | +19.9% |
| FY2024 | $16.75B | $1.85B | $11.49B | $1.25 | $2.65B | 15.5% | +17.6% |
| FY2023 | $14.24B | $1.59B | $9.90B | $1.07 | $1.79B | 16.4% | +12.3% |
| FY2022 | $12.68B | $698.00M | $8.73B | $0.45 | $938.00M | 13.0% | +6.7% |
Figures as reported in BOSTON SCIENTIFIC CORP's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to BSX
Never miss a BSX filing.
Get an email when BSX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.